================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
(Rule 13d-101)
Under the Securities Exchange Act of 1934
(AMENDMENT NO. 2 - FINAL)
CARMIKE CINEMAS, INC.
--------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, $0.03 PAR VALUE
--------------------------------------------------------------------------------
(Title of class of securities)
143436400
--------------------------------------------------------------------------------
(CUSIP number)
JOSEPH A. ORLANDO
VICE PRESIDENT AND CHIEF FINANCIAL OFFICER
LEUCADIA NATIONAL CORPORATION
315 PARK AVENUE SOUTH
NEW YORK, NEW YORK 10010
WITH A COPY TO:
ANDREA A. BERNSTEIN, ESQ.
WEIL, GOTSHAL & MANGES LLP
767 FIFTH AVENUE
NEW YORK, NEW YORK 10153
--------------------------------------------------------------------------------
(Name, address and telephone number of person authorized to receive
notices and communications)
AUGUST 3, 2004
--------------------------------------------------------------------------------
(Date of event which requires filing of this statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box
[_].
Note: Schedules filed in paper format shall include a signed original and five
copies of the Schedule, including all exhibits.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purposes of Section 18 of the Securities Exchange Act of
1934 (the "Exchange Act") or otherwise subject to the liabilities of that
section of the Exchange Act but shall be subject to all other provisions of the
Exchange Act.
(Continued on following pages)
(Page 1 of 9 pages)
================================================================================
NY2:\1485379\01\V%4J01!.DOC\76830.0001
---------------------------------------------------------------------------------- --------------------------------
CUSIP No. 143436400 13D
---------------------------------------------------------------------------------- --------------------------------
---------------------- ----------------------------------------------------------- -----------------------------------------------
1 NAME OF REPORTING PERSON: Leucadia Investors, Inc.
S.S. OR I.R.S. IDENTIFICATION NO.
OF ABOVE PERSON:
---------------------- -----------------------------------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP: (a) [_]
(b) [x]
---------------------- -----------------------------------------------------------------------------------------------------------
3 SEC USE ONLY
---------------------- ------------------------------------- ---------------------------------------------------------------------
4 SOURCE OF FUNDS: N/A
---------------------- -----------------------------------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e): [_]
---------------------- ----------------------------------------------------------- -----------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION: New York
----------------------------------- -------- ---------------------------------------------------- --------------------------------
NUMBER OF 7 SOLE VOTING POWER: -0-
SHARES
-------- ---------------------------------------------------- --------------------------------
BENEFICIALLY 8 SHARED VOTING POWER: -0-
OWNED BY
-------- ---------------------------------------------------- --------------------------------
EACH 9 SOLE DISPOSITIVE POWER: -0-
REPORTING
-------- ---------------------------------------------------- --------------------------------
PERSON WITH 10 SHARED DISPOSITIVE POWER: -0-
---------------------- -------------------------------------------------------------------------- --------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY REPORTING PERSON: -0-
---------------------- -----------------------------------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES: [_]
---------------------- -----------------------------------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11): 0%
---------------------- ----------------------------------------------------------- -----------------------------------------------
14 TYPE OF REPORTING PERSON: CO
---------------------- ----------------------------------------------------------- -----------------------------------------------
Page 2 of 9
---------------------------------------------------------------------------------- --------------------------------
CUSIP No. 143436400 13D
---------------------------------------------------------------------------------- --------------------------------
---------------------- ----------------------------------------------------------- -----------------------------------------------
1 NAME OF REPORTING PERSON: Leucadia, Inc.
S.S. OR I.R.S. IDENTIFICATION NO.
OF ABOVE PERSON:
---------------------- -----------------------------------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP: (a) [_]
(b) [x]
---------------------- -----------------------------------------------------------------------------------------------------------
3 SEC USE ONLY
---------------------- ------------------------------------- ---------------------------------------------------------------------
4 SOURCE OF FUNDS: N/A
---------------------- -----------------------------------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e): [_]
---------------------- ----------------------------------------------------------- -----------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION: New York
----------------------------------- -------- ---------------------------------------------------- --------------------------------
NUMBER OF 7 SOLE VOTING POWER: -0-
SHARES
-------- ---------------------------------------------------- --------------------------------
BENEFICIALLY 8 SHARED VOTING POWER: -0-
OWNED BY
-------- ---------------------------------------------------- --------------------------------
EACH 9 SOLE DISPOSITIVE POWER: -0-
REPORTING
-------- ---------------------------------------------------- --------------------------------
PERSON WITH 10 SHARED DISPOSITIVE POWER: -0-
---------------------- -------------------------------------------------------------------------- --------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY REPORTING PERSON: -0-
---------------------- -----------------------------------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES: [_]
---------------------- -----------------------------------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11): 0%
---------------------- ----------------------------------------------------------- -----------------------------------------------
14 TYPE OF REPORTING PERSON: CO
---------------------- ----------------------------------------------------------- -----------------------------------------------
Page 3 of 9
---------------------------------------------------------------------------------- --------------------------------
CUSIP No. 143436400 13D
---------------------------------------------------------------------------------- --------------------------------
---------------------- ----------------------------------------------------------- -----------------------------------------------
1 NAME OF REPORTING PERSON: Leucadia National Corporation
S.S. OR I.R.S. IDENTIFICATION NO.
OF ABOVE PERSON:
---------------------- -----------------------------------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP: (a) [_]
(b) [x]
---------------------- -----------------------------------------------------------------------------------------------------------
3 SEC USE ONLY
---------------------- ------------------------------------- ---------------------------------------------------------------------
4 SOURCE OF FUNDS: N/A
---------------------- -----------------------------------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e): [_]
---------------------- ----------------------------------------------------------- -----------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION: New York
----------------------------------- -------- ---------------------------------------------------- --------------------------------
NUMBER OF 7 SOLE VOTING POWER: 94,622*
SHARES
-------- ---------------------------------------------------- --------------------------------
BENEFICIALLY 8 SHARED VOTING POWER: -0-
OWNED BY
-------- ---------------------------------------------------- --------------------------------
EACH 9 SOLE DISPOSITIVE POWER: 94,622*
REPORTING
-------- ---------------------------------------------------- --------------------------------
PERSON WITH 10 SHARED DISPOSITIVE POWER: -0-
---------------------- -------------------------------------------------------------------------- --------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY REPORTING PERSON: 94,622*
---------------------- -----------------------------------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES: [_]
---------------------- -----------------------------------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11): 0.8%**
---------------------- ----------------------------------------------------------- -----------------------------------------------
14 TYPE OF REPORTING PERSON: CO
---------------------- ----------------------------------------------------------- -----------------------------------------------
* If the underwriters party to the underwriting agreement, dated
August 3, 2004 (the "Underwriting Agreement"), entered into with
Carmike Cinemas, Inc. (the "Company") and the selling stockholders
party thereto, relating to the Company's public offering of shares of
its Class A Common Stock, exercise the over-allotment option granted
pursuant to the Underwriting Agreement (the "Over-Allotment Option")
in full then this amount will be 0 shares. The Over-Allotment Option
is exercisable within 30 days after the date of the Underwriting
Agreement.
** If the underwriters party to the Underwriting Agreement exercise
the Over-Allotment Option in full then this percentage will equal 0%.
Page 4 of 9
ITEM 1. SECURITY AND ISSUER.
This Amendment No. 2, filed by Leucadia National Corporation
("Leucadia") and its subsidiaries, Leucadia, Inc. ("LI") and Leucadia Investors,
Inc. ("LII"), a subsidiary of LI (collectively, "Beneficial Owners"), amends and
supplements the Schedule 13D filed by the Beneficial Owners with the Securities
and Exchange Commission (the "SEC") on February 11, 2002 (the "Schedule 13D"),
relating to the Class A Common Stock, $0.03 par value per share (the "Common
Stock"), of Carmike Cinemas, Inc., a Delaware corporation (the "Company"). This
Amendment No. 2 represents the final amendment with respect to the Beneficial
Owners. Capitalized terms used herein but not otherwise defined herein shall
have the meanings ascribed to such terms in the Schedule 13D.
ITEM 4. PURPOSE OF THE TRANSACTION.
Item 4 is hereby amended by adding the following at the end thereof:
On August 3, 2004, Leucadia and LII entered into an Underwriting
Agreement (the "Underwriting Agreement") with the Company, the other selling
stockholders listed in Schedule II to the Underwriting Agreement (together with
Leucadia and LII, the "Selling Stockholders"), Goldman, Sachs & Co. ("Goldman
Sachs"), as representative of the several underwriters listed in Schedule I to
the Underwriting Agreement and UBS Securities LLC, as Independent Underwriter
(collectively, the "Underwriters"). The Underwriting Agreement provides for
purchases by the Underwriters from the Selling Stockholders of 4,332,415 shares
of Common Stock (collectively, the "Initial Sale"). Of the 4,332,415 shares of
Common Stock to be sold by the Selling Stockholders in the Initial Sale,
Leucadia has agreed to sell 516,177 shares and LII has agreed to sell 114,903
shares. In addition, pursuant to the Underwriting Agreement, the Selling
Stockholders granted the Underwriters an option, exercisable within 30 days
after the date of the Underwriting Agreement, to purchase an additional 649,836
shares of Common Stock at the same purchase price per share for the purpose of
covering over-allotments (the "Over-Allotment Option"). Of the 649,836 shares of
Common Stock to be sold by the Selling Stockholders upon the exercise in full by
the Underwriters of the Over-Allotment Option, Leucadia has agreed to sell
94,662 shares. Pursuant to the final prospectus (the "Offering Prospectus")
filed by the Company on August 4, 2004 (the "Offering Prospectus Date") pursuant
to Rule 424 of the Securities Act of 1933 (as amended, the "Securities Act"),
the public offering price in the public offering of Common Stock by the Company
is $33.00 per share and the underwriting discount is $1.485 per share. Pursuant
to the Underwriting Agreement, the Underwriters agreed to purchase shares of
Common Stock in the Initial Sale and upon exercise of the Over-Allotment Option
at a price per share of $32.515 (which is net of underwriting discounts and
commissions). The Underwriting Agreement contains standard terms and conditions
for a public offering including customary representations and warranties and
indemnity provisions. The foregoing description of the Underwriting Agreement is
not intended to be complete and is qualified in its entirety by the complete
text of the Underwriting Agreement, a copy of which is filed as Exhibit 4
hereto.
Page 5 of 9
Pursuant to the Underwriting Agreement, LII has agreed to sell
114,903 shares of Common Stock to the Underwriters upon consummation of the
Initial Sale and Leucadia has agreed to sell 610,839 shares of Common Stock to
the Underwriters, consisting of (i) 516,177 shares of Common Stock to be sold
upon consummation of the Initial Sale and (ii) 94,662 shares of Common Stock to
be sold upon exercise in full by the Underwriters of the Over-Allotment Option,
in each case, at a price per share of $31.515 (which is net of underwriting
discounts and commissions), for an aggregate amount of $22,871,759.13 (which
consists of $3,621,168.05 that will be received by LII upon consummation of the
Initial Sale and (b) $16,267,318.15 that will be received by Leucadia upon
consummation of the Initial Sale and $2,982,012.33 that would be received by
Leucadia if the Underwriters exercise the Over-Allotment Option in full). The
consummation of the Initial Sale is expected to occur on August 9, 2004 (the
"Initial Sale Closing Date") as reported by the Company in the Offering
Prospectus.
The Beneficial Owners may, from time to time, acquire additional
shares of the Common Stock (subject to the availability of shares at prices
deemed favorable by the Beneficial Owners), dispose of shares of Common Stock
(subject to the transfer restrictions contained in the Stockholders Agreement
described in Item 6 of the Schedule 13D), engage in discussions with other
stockholders or third parties or some combination of the foregoing.
Although the foregoing represents the possible activities presently
contemplated by the Beneficial Owners with respect to the Company and the Common
Stock, it should be noted that the possible activities of the Beneficial Owners
are subject to change at any time and there is no assurance that the Beneficial
Owners will actually undertake any of the foregoing.
Additional information is included in the response to Item 6 of this
Schedule 13D, which Item is incorporated herein by reference.
Except as set forth above, the Beneficial Owners have no present
plans or intentions which would result in or relate to any of the transactions
described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
(a) Based on information reported by the Company in the Offering
Prospectus, assuming the Initial Sale is consummated on August 9, 2004, there
will be 12,152,622 shares of Common Stock outstanding as of the close of
business on August 9, 2004 (the "Outstanding Shares") and the Beneficial Owners
will beneficially own the following shares of Common Stock:
(i) As of August 9, 2004, LII will no longer own any shares of Common
Stock.
(ii) As of August 9, 2004, Leucadia will be the direct owner of
94,622 shares of Common Stock representing approximately 0.8% of the Outstanding
Page 6 of 9
Shares; provided, however, that if the Underwriters exercise the Over-Allotment
Option in full, then Leucadia will no longer own any shares.
(b) Item 5(a) and Item 6 of the Schedule 13D are incorporated herein
by reference. By virtue of the Stockholders Agreement, the Signing Stockholders
may be deemed to be part of a "group" for purposes of Section 13(d) of the Act,
whose members collectively hold more than 5% of the Company's Common Stock. Each
Beneficial Owner disclaims its membership in such group and disclaims beneficial
ownership of any shares of stock held by any Other Signatories attributed to
them by reason of the Stockholders Agreement. The filing of this Schedule 13D
shall not be construed as an admission that any Beneficial Owner is the
beneficial owner of such shares or that the Beneficial Owners and any of such
other stockholders constitute such a group or "person" for purposes of Section
13(d)(3) of the Act.
(c) Except as set forth above, none of the Beneficial Owners, nor to
the best of their knowledge, any of their executive officers or directors, has
effected any transaction in any securities of the Company during the past 60
days.
(d) Not applicable.
(e) On August 9, 2004, upon consummation of the transactions
described in Item 4 above, the Beneficial Owners ceased to be the beneficial
owners of 5% or more of the Common Stock.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH
RESPECT TO SECURITIES OF THE ISSUER.
Item 6 is hereby amended by adding the following at the end thereof:
The responses set forth in Item 4 of this Schedule 13D are
incorporated herein by reference in their entirety.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
8. Underwriting Agreement, dated August 3, 2004, by and among Carmike
Cinemas, Inc., the Selling Stockholders listed in Schedule II thereto and
Goldman, Sachs & Co., as representative of the several underwriters listed in
Schedule I thereto (filed as Exhibit 99.18 to Amendment No. 3 to the Schedule
13D of Goldman, Sachs & Co., et al, relating to the Company's Common Stock,
filed on August 5, 2004 (the "Goldman, Sachs Schedule 13D").*
-----------------------
* Incorporated herein by reference
Page 7 of 9
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and
correct.
Dated: November 23, 2004
LEUCADIA NATIONAL CORPORATION
/S/ JOSEPH A. ORLANDO
-----------------------------------------
BY: JOSEPH A. ORLANDO
Title: Vice President
LEUCADIA, INC.
/S/ JOSEPH A. ORLANDO
-----------------------------------------
BY: JOSEPH A. ORLANDO
Title: Vice President
LEUCADIA INVESTORS, INC.
/S/ JOSEPH A. ORLANDO
-----------------------------------------
BY: JOSEPH A. ORLANDO
Title: Vice President
Page 8 of 9
EXHIBIT INDEX
Exhibit No. Description Page No.
----------- ----------- --------
8 Underwriting Agreement, dated August 3, 2004,
by and among Carmike Cinemas, Inc., the Selling
Stockholders listed in Schedule II thereto and
Goldman, Sachs & Co., as representative of the
several underwriters listed in Schedule I
thereto (filed as Exhibit 99.18 to Amendment
No. 3 to the Schedule 13D of Goldman, Sachs &
Co., et al, relating to the Company's Common
Stock, filed on August 5, 2004 (the "Goldman,
Sachs Schedule 13D").*
-----------------------
* Incorporated herein by reference
Page 9 of 9